2012
DOI: 10.1099/vir.0.034900-0
|View full text |Cite
|
Sign up to set email alerts
|

Comprehensive mapping of West Nile virus (WNV)- and Japanese encephalitis virus serocomplex-specific linear B-cell epitopes from WNV non-structural protein 1

Abstract: West Nile virus (WNV) non-structural protein 1 (NS1) elicits protective immune responses during infection of animals. WNV NS1-specific antibody responses can provide the basis for serological diagnostic reagents, so the antigenic sites in NS1 that are targeted by host immune responses need to be identified and the conservation of these sites among the Japanese encephalitis virus (JEV) serocomplex members also needs to be defined. The present study describes the mapping of linear B-cell epitopes in WNV NS1. We … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
24
0

Year Published

2012
2012
2019
2019

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 24 publications
(24 citation statements)
references
References 38 publications
0
24
0
Order By: Relevance
“…A set of 42 partially overlapping polypeptides, each 16 amino acids in length, covering the entirety of the EEEV E2 protein (E2-1 to E2-42, Table S1) were generated in our laboratory according to the methods previously described [35], [36]. The E2 sequence used for the experiments in this study was synthesized from an EEEV NA variant strain (GenBank accession number X63135.1) and cloned into pCI-neo, and maintained in our laboratory.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A set of 42 partially overlapping polypeptides, each 16 amino acids in length, covering the entirety of the EEEV E2 protein (E2-1 to E2-42, Table S1) were generated in our laboratory according to the methods previously described [35], [36]. The E2 sequence used for the experiments in this study was synthesized from an EEEV NA variant strain (GenBank accession number X63135.1) and cloned into pCI-neo, and maintained in our laboratory.…”
Section: Methodsmentioning
confidence: 99%
“…The E2 sequence used for the experiments in this study was synthesized from an EEEV NA variant strain (GenBank accession number X63135.1) and cloned into pCI-neo, and maintained in our laboratory. The plasmid pShuttle-E2 were constructed and maintained in our laboratory [35], [36].…”
Section: Methodsmentioning
confidence: 99%
“…Purified WNV NS1 protein and 35 partially overlapping, MBP-fused polypeptides covering the entire WNV NS1 protein (NS1-1 to NS1-35) (Data S1) were generated in our laboratory as previously described [57].…”
Section: Methodsmentioning
confidence: 99%
“…The ELISA was performed as described previously, using synthesized polypeptides as coating antigen (100 ng/well) [57]. The irrelevant polypeptide (V5-Tag: GKPIPNPLLGLDST) and serum from unimmunized animals served as negative controls.…”
Section: Methodsmentioning
confidence: 99%
“…The ELISA assay used has been described previously (Sun et al, 2011(Sun et al, , 2012. Briefly, microplates were sensitized at 4 8C overnight with purified His 6 -BTV16 VP5d41aa at 100 ng ml À1 .…”
Section: Production and Identification Of Mabs Against Btv16 Vp5 Proteinmentioning
confidence: 99%